Manufacturer record
Celebrity Biopharma Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Celebrity Biopharma Ltd (Himachal Pradesh) were declared Not of Standard Quality between August 2019 and September 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Celebrity Biopharma Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cipronir 500 (Ciprofloxacin Tablets IP 500 mg) | CCF212003Mfg 2022-12 · Exp 2025-11 | DissolutionDissolution | CDL KolkataCDSCO lab | Sep 2024 |
| Ciprofloxacin Tablets IP 500 mg Cipronir 500 | CCF111004Mfg 2021-11 · Exp 2024-10 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2023 |
| Ciprofloxacin Tablets I.P. 500 mg. (Cipronir-500) | CCF912011Mfg 2019-12 · Exp 2022-11 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2021 |
| Atorvastatin Calcium Tablets IP 10 mg | CATO009001Mfg 2020-09 · Exp 2022-08 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Nov 2021 |
| (CARVEDILOL TABLETS IP 6.25 MG) | CADG904001Mfg 2019-04 · Exp 2021-03 | AssayAssay | RDTL ChandigarhState lab | Jul 2020 |
| Eufox-O (Ofloxacin and Ornidazole Tablets) | CJM711031Mfg 2017-11 · Exp 2020-10 | DisintegrationDisintegration | CDL KolkataCDSCO lab | Aug 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.